GSTM1 and rs175174: Understanding Genetic Detoxification
The GSTM1 gene encodes an enzyme critical for detoxifying harmful compounds and managing oxidative stress in the body. Variations in this gene, including the well-studied null deletion and associated SNPs like rs175174, have been investigated for their potential links to hypertension and vascular disease susceptibility.
What each genotype means
Functional enzyme activity
This genotype indicates the presence of the GSTM1 gene, which is responsible for producing enzymes that help the body detoxify certain substances. Research suggests that individuals with this genotype maintain standard enzyme function compared to those with the null genotype. This is considered the reference state for the gene.
Carried by a significant portion of the global population, though frequencies vary widely by ancestry.
Intermediate enzyme activity
This genotype suggests the presence of at least one functional copy of the GSTM1 gene. While research often focuses on the complete absence of the gene, having one copy may provide partial enzyme activity. The clinical significance of this intermediate state is less clearly defined than the null genotype.
Commonly observed in many populations, representing a heterozygous state for the GSTM1 variant.
Reduced enzyme activity
This genotype is often associated with the 'null' state, where the GSTM1 gene is absent or inactive, leading to decreased detoxification capacity. Some studies have linked this null genotype to a slightly higher risk of conditions like hypertension or oxidative stress, though the evidence is limited and inconsistent across different populations. This is not a diagnosis, and any concerns regarding health risks should be discussed with a healthcare provider.
The null genotype is common worldwide, with frequencies often ranging between 30% and 40% depending on the specific ancestral background.
What is the GSTM1 Gene?
The GSTM1 gene provides instructions for making an enzyme called glutathione S-transferase mu 1. This enzyme belongs to a larger family of proteins that play a vital role in cellular detoxification. By attaching glutathione to various toxins, carcinogens, and oxidative byproducts, these enzymes help neutralize potentially harmful substances, making them easier for the body to eliminate. Because of this function, GSTM1 is highly active in tissues like the liver and kidneys, where it helps protect cells from damage caused by reactive oxygen species. When GSTM1 activity is reduced or absent, the body may be less efficient at managing oxidative stress, a condition where the production of harmful free radicals outpaces the body's ability to neutralize them.
Understanding the Variant and Its Context
While the GSTM1 gene is often discussed in the context of a 'null' deletion—where the entire gene is missing—researchers also study specific single nucleotide polymorphisms (SNPs) like rs175174 to understand how subtle genetic differences influence enzyme function. SNPs are small, single-letter changes in the DNA sequence. In the case of GSTM1, these variations are often studied to see if they correlate with differences in how well an individual's detoxification pathways function. It is important to note that the relationship between a single SNP and a complex health outcome is rarely straightforward. Many factors, including other genes, environmental exposures, and diet, interact to determine how a specific genetic variant influences overall health. Scientists use large-scale studies to determine if these variants appear more frequently in individuals with certain health conditions compared to the general population.
Research Associations and Evidence Strength
The evidence linking GSTM1 variants to health outcomes is considered limited and sometimes inconsistent. Research has explored whether reduced GSTM1 activity contributes to hypertension and chronic kidney disease, as oxidative stress is a known factor in the progression of these conditions. Some meta-analyses have suggested a modest association between the GSTM1 null genotype and an increased risk of hypertension, with odds ratios indicating a slight elevation in risk. However, other studies have failed to replicate these findings, highlighting the complexity of translating experimental findings from animal models to human populations. Because human health is influenced by a vast array of genetic and lifestyle factors, it is difficult to isolate the effect of a single variant. Consequently, while the biological role of GSTM1 is well-established, the clinical utility of testing for specific variants like rs175174 remains a subject of ongoing scientific investigation rather than established clinical practice.
Population Frequency
The GSTM1 gene is characterized by significant variability across different human populations. The 'null' genotype, where the gene is absent, is quite common, appearing in a large percentage of individuals worldwide. Because of this high frequency, researchers often compare the health outcomes of those with the functional gene versus those without it. For specific SNPs within the gene, frequencies can vary significantly based on ancestral background. Understanding these frequencies is essential for researchers to ensure that genetic studies are representative of diverse populations, as a variant that appears to be a risk factor in one group may not show the same association in another.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs175174 is primarily for educational purposes and should not be used to make medical decisions. If you are concerned about your cardiovascular health or blood pressure, the most effective steps involve working with a healthcare professional to monitor your blood pressure, maintain a heart-healthy diet, and engage in regular physical activity. You cannot use this genetic information to diagnose a condition or predict your future health with certainty. If you have questions about how your genetics might influence your health or your response to specific medications, please discuss these concerns with your clinician or a qualified genetic counselor. They can provide context based on your personal and family medical history, which is far more predictive of health outcomes than any single genetic variant.
How common is this variant?
The GSTM1 gene variants are common worldwide, with the minor allele frequency for many associated SNPs typically ranging between 30% and 40%.
Frequently asked questions
Is the GSTM1 null genotype a disease?
No, the GSTM1 null genotype is not a disease. It is a common genetic variation where an individual lacks the GSTM1 gene, and many people with this genotype live healthy lives without any clinical symptoms.
Can I change my GSTM1 expression?
You cannot change your underlying DNA sequence. However, research suggests that environmental factors, such as diet, may influence how genes are expressed and how the body manages oxidative stress.
Should I get tested for GSTM1 variants?
Routine testing for GSTM1 variants is not currently recommended for clinical diagnosis. If you have concerns about your health, focus on established clinical markers like blood pressure and cholesterol levels with your doctor.
Does this variant affect how I process medication?
While GSTM1 is involved in detoxification, there is no standard clinical guidance for adjusting medications based on this specific SNP. Always consult your pharmacist or physician before making changes to your prescribed treatments.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs175174?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GSTM1
Single-nucleotide polymorphism tagging glutathione S-transferase M1 functional status, influencing xenobiotic detoxification and chemotherapy efficacy/toxicity.
The GSTM1 null genotype involves a gene deletion that results in a complete loss of enzyme activity, impacting the detoxification of various environmental toxins and drugs.